Mine & Arao Wealth Creation & Management, Llc. Vir Biotechnology, Inc. Transaction History

Mine & Arao Wealth Creation & Management, Llc.

$218 Million
Q4 2024

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 13, 2022	BUY	$21.19 - $40.01 $2,436 - $4,601	115 New	115 $3,000

Others Institutions Holding VIR

# of Institutions

231

Shares Held

90.1M

Call Options Held

1.28M

Put Options Held

235K

Sb Investment Advisers (Uk) LTD London, X0

16.7M
Shares

$160 Million
1.08% of portfolio
Black Rock Inc. New York, NY

16.4M
Shares

$157 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13.1M
Shares

$126 Million
0.0% of portfolio
State Street Corp Boston, MA

5.07M
Shares

$48.6 Million
0.0% of portfolio
Orbimed Advisors LLC San Diego, CA

3.22M
Shares

$30.8 Million
0.64% of portfolio

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $1.27B
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mine & Arao Wealth Creation & Management, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Mine & Arao Wealth Creation & Management, Llc. with notifications on news.

Account